Raily Aesthetic Medicine International Holdings Limited (HKG:2135)
Hong Kong · Delayed Price · Currency is HKD 0.1200
+0.0010 (0.84%)
Sep 2, 2026, 3:23 PM HKT
HKG:2135 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 219.59 | 189.41 | 199.34 | 189.38 | 164.52 | 188.37 | |
Revenue Growth | 31.91% | -4.98% | 5.26% | 15.11% | -12.66% | 14.48% |
Cost of Revenue | 126.94 | 111.7 | 127.94 | 117.89 | 97.74 | 118.68 |
Gross Profit | 92.65 | 77.71 | 71.41 | 71.49 | 66.78 | 69.69 |
Selling, General & Admin | 69.98 | 69.1 | 89.47 | 92.39 | 85.17 | 89.26 |
Research & Development | 2.66 | 2.07 | 0.72 | 1.6 | 2 | - |
Other Operating Expenses | 1.36 | 1.36 | 0.09 | 0.03 | - | - |
Operating Expenses | 74 | 72.53 | 90.28 | 94.02 | 87.17 | 89.26 |
Operating Income | 18.66 | 5.18 | -18.87 | -22.52 | -20.39 | -19.57 |
Interest Expense | -2.34 | -2.75 | -2.81 | -2.8 | -2.8 | -2.42 |
Interest & Investment Income | 0.6 | 0.6 | 0.4 | 0.84 | 0.73 | 1.23 |
Earnings From Equity Investments | -0.54 | -0.61 | -0.08 | -1.74 | -0.16 | -0.15 |
Currency Exchange Gain (Loss) | - | - | - | 0.24 | 2.64 | - |
Other Non Operating Income (Expenses) | -3.06 | -2.66 | -62.41 | -16.4 | -6.49 | -3.12 |
EBT Excluding Unusual Items | 13.32 | -0.24 | -83.77 | -42.39 | -26.47 | -24.02 |
Gain (Loss) on Sale of Assets | 0.25 | 0.25 | 0.07 | 0.16 | - | - |
Other Unusual Items | - | - | 18.44 | 7.22 | 4.36 | 1.07 |
Pretax Income | 13.57 | 0.01 | -65.26 | -35.01 | -22.1 | -22.95 |
Income Tax Expense | 2.8 | 2.21 | -1.99 | 2.77 | -1.85 | -4.68 |
Earnings From Continuing Operations | 10.77 | -2.2 | -63.26 | -37.78 | -20.25 | -18.27 |
Minority Interest in Earnings | 2.77 | 4.07 | 4.05 | 5.32 | 4.34 | 0.58 |
Net Income | 13.54 | 1.87 | -59.21 | -32.46 | -15.91 | -17.69 |
Net Income to Common | 13.54 | 1.87 | -59.21 | -32.46 | -15.91 | -17.69 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 556 | 557 | 533 | 418 | 418 | 417 |
Shares Outstanding (Diluted) | 556 | 557 | 533 | 418 | 418 | 417 |
Shares Change | -0.29% | 4.55% | 27.53% | - | 0.08% | 21.62% |
EPS (Basic) | 0.02 | 0.00 | -0.11 | -0.08 | -0.04 | -0.04 |
EPS (Diluted) | 0.02 | 0.00 | -0.11 | -0.08 | -0.04 | -0.04 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 33.98 | -2.64 | -9.98 | -21.13 | -18.23 |
Free Cash Flow Per Share | - | 0.06 | -0.01 | -0.02 | -0.05 | -0.04 |
Gross Margin | 42.19% | 41.03% | 35.82% | 37.75% | 40.59% | 37.00% |
Operating Margin | 8.50% | 2.73% | -9.47% | -11.89% | -12.39% | -10.39% |
Profit Margin | 6.17% | 0.99% | -29.70% | -17.14% | -9.67% | -9.39% |
Free Cash Flow Margin | - | 17.94% | -1.32% | -5.27% | -12.84% | -9.68% |
EBITDA | 32.11 | 18.96 | -1.53 | -7.03 | -7.05 | -11.58 |
EBITDA Margin | 14.62% | 10.01% | -0.77% | -3.71% | -4.29% | -6.15% |
D&A For EBITDA | 13.46 | 13.78 | 17.34 | 15.5 | 13.33 | 7.98 |
EBIT | 18.66 | 5.18 | -18.87 | -22.52 | -20.39 | -19.57 |
EBIT Margin | 8.50% | 2.73% | -9.47% | -11.89% | -12.39% | -10.39% |
Effective Tax Rate | 20.60% | 22070.00% | - | - | - | - |